R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism

European Journal of Endocrinology

Volumn 155, Issue 5, 2006, Pages 687-692

  Corbetta, S ^a   Eller Vainicher, C ^a   Filopanti, M ^a   Saeli, P ^a   Vezzoli, G ^b   Arcidiacono, T ^b   Loli, P ^c   Syren, M L ^a   Soldati, L ^a   Beck Peccoz, P ^a   Spada, Anna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE DISEASE; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; URINARY EXCRETION;

AGED; AMINO ACID SUBSTITUTION; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERTENSION; MALE; NEPHROLITHIASIS; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RECEPTORS, CALCIUM-SENSING;

EID: 33845276341     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02286     Document Type: Article

References (35)

1. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akerstrom G & Melhus H. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Medicine 1995 1 1309-1311.
2. Kobayashi T, Sugimoto T, Kobayashi A & Chihara K. Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism. Endocrine Journal 1998 45123-45125.
3. Carling T, Rastad J, Kindmark A, Lundgren E, Ljunghall S & Akerstrom G. Estrogen receptor gene polymorphisms in post-menopausal primary hyperparathyroidism. Surgery 1997 122 1101-1106.
4. Kanzawa M, Sugimoto T, Kobayashi T, Kobayashi A & Chihara K. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism. Clinical Endocrinology 1999 50 583-588.
5. Chattopadhyay N, Mithal A & Brown EM. The calcium sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocrine Review 1996 17 289-307.
6. Brown EM & McLeod JR. Extracellular calcium sensing and extracellular calcium signaling. Endocrine Review 2001 81 239-297.
7. 2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993 75 1297-1303.
8. 2+ sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Human Genetics 1996 98 129-133.
9. Hendy GN, D'Souza-Li L, Yang B, Canaff L & Cole DE. Mutations of the calcium-sensing receptor (CaSR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Human Mutations 2000 16 281-296.
10. 2+-sensing receptor gene in human parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 1995 80 3107-3110.
11. Cetani F, Pinchera A, Pardi E, Cianferotti L, Vignali E, Picone A, Miccoli P, Viacava P & Marcocci C. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. Journal of Bone and Mineral Research 1999 14 878-882.
12. Heath HIII, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano G, IV, arrett JE & Leitket MF. Clustered inactivating mutations and benign polymorphisms of the calcium sensing receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. Journal of Clinical Endocrinology and Metabolism 1996 81 1312-1317.
13. Cole DEC, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang DM, Evrovski J & Hendy GN. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999 353 112-115.
14. Lorentzon M, Lorentzon R, Lerner UH & Nordström P. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. European Journal of Endocrinology 2001 144 257-261.
15. Bollerslev J, Wilson SG, Dick IM, Devine A, Dhaliwal SS & Prince IR. Calcium sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcified Tissue International 2004 74 12-17.
16. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN & Cole DEC. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. Journal of Clinical Endocrinology and Metabolism 2004 89 5634-5638.
17. Yano S, Sugimoto T & Kanzawa M. Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 2000 85 317-323.
18. Yamauchi M, Sugimoto T, Yamaguchi T, Yano S, Kanzawa M, Kobayashi A & Chihara K. Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clinical Endocrinology 2001 55 373-379.
19. Miedlich S, Lamesch P, Mueller A & Paschke R. Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. European Journal of Endocrinology 2001 145 421-427.
20. Cetani F, Borsari S, Vignali E, Pardi E, Picone A, Cianferotti L, Rossi G, Miccoli P, Pinchera A & Marcocci C. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. Journal of Endocrinological Investigation 2002 25 614-619.
21. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G & Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-former patients. Journal of the American Society of Nephrology 2002 13 2517-2523.
22. Potts JT (Ed.). NIH Consensus development conference statement on primary hyperparathyroidism. Journal of Bone and Mineral Research 1991 6:S9-S13.
23. Corbetta S, Baccarelli A, Aroldi A, Vicentini L, Fogazzi GB, Eller-Vainicher C, Ponticelli C, Beck-Peccoz P & Spada A. Risk factors associated to kidney stones in primary hyperparathyroidism. Journal of Endocrinological Investigation 2005 28 122-128.
24. Fuleihan GE, Seifter J, Scott J & Brown EM. Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. Journal of Clinical Endocrinology and Metabolism 1998 83 2366-2372.
25. Walton RJ & Bijvoet OLM. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975 16 309-310.
26. Filopanti M, Ronchi C, Ballarè E, Bondioni S, Lania AG, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P & Spada A. Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4824-4828.
27. Ba J, Brown D & Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. American Journal Physiology - Renal Physiology 2003 285 1233-1243.
28. Prie D, Beck L, Urena P & Friedlander G. Recent findings in phosphate homeostasis. Current Opinion in Nephrology and Hypertension 2005 14 318-324.
29. Kobayshi K, Imanishi Y, Miyauchi A, Oneda N, Kawata Y, Tahara H, Goto H, Miki T, Ishimura F, Sugimoto T, Ishikawa T, Inaba M & Nishizawa Y. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. European Journal of Endocrinology 2006 154 93-99.
30. Bilezikian JP, Silverberg SJ, Shane E, Parisien M & Dempster DW. Characterization and evaluation of asymptomatic primary hyperparathyroidism. Journal of Bone and Mineral Research 1991 (Suppl 2) S85-S89.
31. Silverberg SJ, Shane E, Jacobs TP, Siris E & Bilezikian JR A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine 1999 341 1249-1255.
32. 2+ activation of the human calcium sensing receptor. A study with receptor-green fluorescent protein fusions. Journal of Biological Chemistry 1998 273 29712-29718.
33. Hjalm G, MacLeod RH, Kifor O, Chattopadhyay N & Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. Journal of Biological Chemistry 2001 276 34880-34887.
34. Yokoyama K, Shigematsu T, Tsukada T, Hara S, Yamada S, Kawaguch Y & Hosoya T. Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease. Clinical Nephrology 2002 57 131-135.
35. Rothe HM, Shapiro WB, Sun WY & Chou S-Y. Calcium-sensing receptor gene polymorphism R990G and its possible effect on response to cinacalcet HCl. Pharmacogenetics and Genomics 2005 15 29-34.